New Management Has Led SOL Global Through Execution of Strategic Transactions Resulting in Pre-Tax Net Income of $110.8 million HeavenlyRx has commenced negotiations and due diligence for a U.S. Listing. SOL Global to acquire the remaining shares of its portfolio company, CannCure, along...